Beginning June 26 at 5:30pm ET, PAN’s call center and portals will be closed as we transition to the new unified TotalAssist program. We encourage you to complete any enrollments, grant management tasks, or time-sensitive claim submissions prior to June 26. Our new call center and TotalAssist portals will be available again starting July 1 at 8:30am ET. All active and recently expired (January 1, 2026, or later) PAN legacy grant information will be available again on July 1 via the TotalAssist portal. The new portal can be found at TotalAssist.org. The call center can be reached by calling toll free, 866-512-3861.

PAN Foundation submits letter in support of act to expand Medicare coverage of obesity treatment medications

The PAN Foundation submitted a letter to Senators Ben Ray Luján and Bill Cassidy, M.D., in support of S.1973, the Treat and Reduce Obesity Act (TROA). This critical legislation will help ensure that obesity treatment medications accessible to millions of Medicare beneficiaries. Medicare is currently barred from covering FDA-approved anti-obesity medications (AOMs) under Part D, including GLP-1 agonists and similar medications prescribed for the treatment of obesity.

Expanding Medicare Part D coverage of AOMs will help enrollees access needed medications prescribed by their healthcare providers. High out-of-pocket costs of AOMs result in patients reporting that they ration, skip, or discontinue their medications. Expanded Medicare coverage of obesity care is vital to improving health outcomes and securing long-term savings for the U.S. healthcare system and taxpayer.

Read PAN’s letters to Senator Luján and Senator Cassidy

Explore policy letters and testimony

  • Subscribe to news

    Sign up to receive PAN news, from helpful articles to action alerts.

    Subscribe today

  • Take action

    Voice your support for healthcare access and affordability.

    Take action now

  • Donate today

    Make your life-changing donation to support healthcare access.

    Donate online